Results 251 to 260 of about 458,215 (302)

Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis. [PDF]

Ann Neurosci
Mathur D, Mishra SV, Rout S, Kandimalla R, López-Iranzo FJ, López-Rodas G, Vinayak R, Casanova B, Mishra BK.   +8 more
europepmc   +1 more source

Menopause is a physiological progression event for women with multiple sclerosis: No. [PDF]

Mult Scler
Jokubaitis VG.
europepmc   +1 more source

Clocks out of sync: Increased epigenetic aging variability in multiple sclerosis. [PDF]

J Neurol Sci
Schumacher FL, Cutter G, Burd CE, Archer K, Zhang Y.   +4 more
europepmc   +1 more source

Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis. [PDF]

Hum Brain Mapp
Colman J, Pontillo G, Goodkin O, Foster MA, Mahmoudi N, Wattjes MP, Brunetti A, Gonzalez-Escamilla G, Groppa S, Høgestøl EA, Westlye LT, Messina S, Palace J, Cortese R, De Stefano N, Rovira À, Sastre-Garriga J, Ropele S, Enzinger C, Rocca MA, Filippi M, Bellenberg B, Lukas C, Calabrese M, Castellaro M, Uher T, Vaneckova M, Toosy A, Ciccarelli O, Yousry T, Prados F, Barkhof F, Cole JH, MAGNIMS Study Group.   +33 more
europepmc   +1 more source

The Crossroads of Neuroinflammation and Biomarkers in Multiple Sclerosis: A Systematic Review. [PDF]

Cells
Gavrilă MG, Albu CV, Albu BC, Burada E, Sandu RE, Surugiu R.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multiple Sclerosis

New England Journal of Medicine, 2000
Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually ...
J H Noseworthy, Claudia Lucchinetti, Moses Rodríguez   +2 more
exaly   +6 more sources